JEFFREY MONTGOMERY: Open Payments
NPI 1902007990 · CLARKS SUMMIT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,865 in 229 payments from 26 companies in 2025. Trend: 2023 $2,824 · 2024 $2,528 · 2025 $7,865
Consulting: $4,313Food & beverage: $3,552
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $5,034 |
| Novo Nordisk Inc | 27 | $411 |
| AstraZeneca Pharmaceuticals LP | 10 | $322 |
| PFIZER INC. | 25 | $319 |
| Lilly USA, LLC | 23 | $284 |
| Amgen Inc. | 8 | $215 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $184 |
| Kowa Pharmaceuticals America, Inc. | 14 | $167 |
| Aimmune Therapeutics, Inc. | 9 | $135 |
Products named: QULIPTA, UBRELVY, JARDIANCE, AIRSUPRA, VRAYLAR, Ozempic, Kerendia, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
